158 related articles for article (PubMed ID: 9316392)
1. Proteasome inhibitors and antigen presentation.
Bogyo M; Gaczynska M; Ploegh HL
Biopolymers; 1997; 43(4):269-80. PubMed ID: 9316392
[TBL] [Abstract][Full Text] [Related]
2. A proteolytic system that compensates for loss of proteasome function.
Glas R; Bogyo M; McMaster JS; Gaczynska M; Ploegh HL
Nature; 1998 Apr; 392(6676):618-22. PubMed ID: 9560160
[TBL] [Abstract][Full Text] [Related]
3. Antigen processing by the proteasome.
Kloetzel PM
Nat Rev Mol Cell Biol; 2001 Mar; 2(3):179-87. PubMed ID: 11265247
[TBL] [Abstract][Full Text] [Related]
4. Distinct proteolytic processes generate the C and N termini of MHC class I-binding peptides.
Mo XY; Cascio P; Lemerise K; Goldberg AL; Rock K
J Immunol; 1999 Dec; 163(11):5851-9. PubMed ID: 10570269
[TBL] [Abstract][Full Text] [Related]
5. The proteasome activator 11 S REG (PA28) and class I antigen presentation.
Rechsteiner M; Realini C; Ustrell V
Biochem J; 2000 Jan; 345 Pt 1(Pt 1):1-15. PubMed ID: 10600633
[TBL] [Abstract][Full Text] [Related]
6. Arecoline tripeptide inhibitors of proteasome.
Marastoni M; Baldisserotto A; Canella A; Gavioli R; Risi CD; Pollini GP; Tomatis R
J Med Chem; 2004 Mar; 47(6):1587-90. PubMed ID: 14998343
[TBL] [Abstract][Full Text] [Related]
7. Proteasomes: destruction as a programme.
Hilt W; Wolf DH
Trends Biochem Sci; 1996 Mar; 21(3):96-102. PubMed ID: 8882582
[TBL] [Abstract][Full Text] [Related]
8. Proteasome inhibitors.
Reboud-Ravaux M
Prog Mol Subcell Biol; 2002; 29():110-25. PubMed ID: 11908069
[No Abstract] [Full Text] [Related]
9. Activation of the multicatalytic endopeptidase by oxidants. Effects on enzyme structure.
Strack PR; Waxman L; Fagan JM
Biochemistry; 1996 Jun; 35(22):7142-9. PubMed ID: 8679541
[TBL] [Abstract][Full Text] [Related]
10. The multicatalytic proteinase complex (proteasome) and intracellular protein degradation: diverse functions of an intracellular particle.
Orlowski M
J Lab Clin Med; 1993 Feb; 121(2):187-9. PubMed ID: 8381842
[No Abstract] [Full Text] [Related]
11. Post-proteasomal antigen processing for major histocompatibility complex class I presentation.
Rock KL; York IA; Goldberg AL
Nat Immunol; 2004 Jul; 5(7):670-7. PubMed ID: 15224092
[TBL] [Abstract][Full Text] [Related]
12. CD8+ T cell cross-priming via transfer of proteasome substrates.
Norbury CC; Basta S; Donohue KB; Tscharke DC; Princiotta MF; Berglund P; Gibbs J; Bennink JR; Yewdell JW
Science; 2004 May; 304(5675):1318-21. PubMed ID: 15166379
[TBL] [Abstract][Full Text] [Related]
13. [The proteasome: destroy to live].
Abramova EB; Sharova NP; Karpov VL
Mol Biol (Mosk); 2002; 36(5):761-76. PubMed ID: 12391838
[TBL] [Abstract][Full Text] [Related]
14. Age-dependent association of isolated bovine lens multicatalytic proteinase complex (proteasome) with heat-shock protein 90, an endogenous inhibitor.
Wagner BJ; Margolis JW
Arch Biochem Biophys; 1995 Nov; 323(2):455-62. PubMed ID: 7487111
[TBL] [Abstract][Full Text] [Related]
15. The role of the ubiquitin-proteasome pathway in apoptosis.
Orlowski RZ
Cell Death Differ; 1999 Apr; 6(4):303-13. PubMed ID: 10381632
[TBL] [Abstract][Full Text] [Related]
16. Rapid deubiquitination of nucleosomal histones in human tumor cells caused by proteasome inhibitors and stress response inducers: effects on replication, transcription, translation, and the cellular stress response.
Mimnaugh EG; Chen HY; Davie JR; Celis JE; Neckers L
Biochemistry; 1997 Nov; 36(47):14418-29. PubMed ID: 9398160
[TBL] [Abstract][Full Text] [Related]
17. The components of the proteasome system and their role in MHC class I antigen processing.
Krüger E; Kuckelkorn U; Sijts A; Kloetzel PM
Rev Physiol Biochem Pharmacol; 2003; 148():81-104. PubMed ID: 12687403
[TBL] [Abstract][Full Text] [Related]
18. Probing the proteasome pathway.
Goldberg AL
Nat Biotechnol; 2000 May; 18(5):494-6. PubMed ID: 10802613
[No Abstract] [Full Text] [Related]
19. The NS2 protein generated by the parvovirus minute virus of mice is degraded by the proteasome in a manner independent of ubiquitin chain elongation or activation.
Miller CL; Pintel DJ
Virology; 2001 Jul; 285(2):346-55. PubMed ID: 11437668
[TBL] [Abstract][Full Text] [Related]
20. The proteasome system and proteasome inhibitors in stroke: controlling the inflammatory response.
Di Napoli M; Papa F
Curr Opin Investig Drugs; 2003 Nov; 4(11):1333-42. PubMed ID: 14758773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
